{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:20:43Z","timestamp":1778545243670,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13075-015-0785-0","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T09:17:19Z","timestamp":1443518239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Sho","family":"Mokuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamoto","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Takasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Masumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"785_CR1","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/JVI.68.4.2521-2528.1994","volume":"68","author":"MJ Birnbaum","year":"1994","unstructured":"Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys\/His sequence motifs. J Virol. 1994;68:2521\u20138.","journal-title":"J Virol"},{"key":"785_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0959-440X(96)80060-1","volume":"6","author":"KL Borden","year":"1996","unstructured":"Borden KL, Freemont PS. The RING finger domain: a recent example of a sequence-structure family. Curr Opin Struct Biol. 1996;6:395\u2013401.","journal-title":"Curr Opin Struct Biol"},{"key":"785_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","volume":"430","author":"DC Altieri","year":"2010","unstructured":"Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J. 2010;430:199\u2013205.","journal-title":"Biochem J"},{"key":"785_CR4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917\u201321.","journal-title":"Nat Med"},{"key":"785_CR5","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.onc.1202569","volume":"17","author":"EC LaCasse","year":"1998","unstructured":"LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247\u201359.","journal-title":"Oncogene"},{"key":"785_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","volume":"3","author":"DC Altieri","year":"2003","unstructured":"Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3:46\u201354.","journal-title":"Nat Rev Cancer"},{"key":"785_CR7","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1186\/ar1498","volume":"7","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Lindblad S, Bokarew D, Tarkowski A. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R349\u201358.","journal-title":"Arthritis Res Ther"},{"key":"785_CR8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0165-5728(01)00389-7","volume":"119","author":"MK Sharief","year":"2001","unstructured":"Sharief MK, Semra YK. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. J Neuroimmunol. 2001;119:358\u201364.","journal-title":"J Neuroimmunol"},{"key":"785_CR9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3899\/jrheum.091087","volume":"37","author":"Y Koike","year":"2010","unstructured":"Koike Y, Muroi E, Yoshizaki A, Ogawa F, Yanaba K, Takenaka M, et al. Autoantibody against survivin in patients with systemic sclerosis. J Rheumatol. 2010;37:1864\u201370.","journal-title":"J Rheumatol"},{"key":"785_CR10","doi-asserted-by":"crossref","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581\u201390.","DOI":"10.1002\/art.1780230510"},{"key":"785_CR11","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"785_CR12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"785_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"H Penn","year":"2007","unstructured":"Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007;100:485\u201394.","journal-title":"QJM"},{"key":"785_CR14","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1002\/art.27695","volume":"62","author":"R Saggar","year":"2010","unstructured":"Saggar R, Khanna D, Furst DE, Shapiro S, Maranian P, Belperio JA, et al. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum. 2010;62:3741\u201350.","journal-title":"Arthritis Rheum"},{"key":"785_CR15","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1038\/srep09795","volume":"5","author":"S Mokuda","year":"2015","unstructured":"Mokuda S, Miyazaki T, Ito Y, Satoshi Y, Hiroko I, Yun G, et al. The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. Sci Rep. 2015;5:9795.","journal-title":"Sci Rep"},{"key":"785_CR16","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108:4009\u201317.","journal-title":"Blood"},{"key":"785_CR17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.0906561","volume":"82","author":"A Landi","year":"2007","unstructured":"Landi A, Babiuk LA. van Drunen Littel-van den Hurk S. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol. 2007;82:849\u201360.","journal-title":"J Leukoc Biol"},{"key":"785_CR18","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.4049\/jimmunol.151.11.6535","volume":"151","author":"FO Nestle","year":"1993","unstructured":"Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol. 1993;151:6535\u201345.","journal-title":"J Immunol"},{"key":"785_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3683","volume":"14","author":"B Malissen","year":"2014","unstructured":"Malissen B, Tamoutounour S, Henri S. The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol. 2014;14:417\u201328.","journal-title":"Nat Rev Immunol"},{"key":"785_CR20","first-page":"6097","volume":"59","author":"C Mahotka","year":"1999","unstructured":"Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999;59:6097\u2013102.","journal-title":"Cancer Res"},{"key":"785_CR21","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.4049\/jimmunol.169.9.4770","volume":"169","author":"X Cao","year":"2002","unstructured":"Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ, et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol. 2002;169:4770\u20137.","journal-title":"J Immunol"},{"key":"785_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11926-002-0006-0","volume":"4","author":"Y Mori","year":"2002","unstructured":"Mori Y, Kahari VM, Varga J. Scleroderma-like cutaneous syndromes. Curr Rheumatol Rep. 2002;4:113\u201322.","journal-title":"Curr Rheumatol Rep"},{"key":"785_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ni.2790","volume":"15","author":"A Jong de","year":"2014","unstructured":"de Jong A, Cheng TY, Huang S, Gras S, Birkinshaw RW, Kasmar AG, et al. CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Immunol. 2014;15:177\u201385.","journal-title":"Nat Immunol"},{"key":"785_CR24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.1956","volume":"11","author":"A Jong de","year":"2010","unstructured":"de Jong A, Pe\u00f1a-Cruz V, Cheng TY, Clark RA, Van Rhijn I, Moody DB. CD1a-autoreactive T cells are a normal component of the human \u03b1\u03b2 T cell repertoire. Nat Immunol. 2010;11:1102\u20139.","journal-title":"Nat Immunol"},{"key":"785_CR25","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","volume":"117","author":"LC Zaba","year":"2007","unstructured":"Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA. Normal human dermis contains distinct populations of CD11c\u2009+\u2009BDCA-1+ dendritic cells and CD163\u2009+\u2009FXIIIA+ macrophages. J Clin Invest. 2007;117:2517\u201325.","journal-title":"J Clin Invest"},{"key":"785_CR26","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011;7:e1002178.","journal-title":"PLoS Genet"},{"key":"785_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood-2002-04-1088","volume":"101","author":"J Aliberti","year":"2003","unstructured":"Aliberti J, Shulz O, Pennington DJ, Tsujimura H. Reis e Sousa C, Ozato K, et al. Essential role for ICSBP in the in vivo development of murine CD8alpha\u2009+\u2009dendritic cells. Blood. 2003;101:305\u201310.","journal-title":"Blood"},{"key":"785_CR28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1084\/jem.20021263","volume":"196","author":"G Schiavoni","year":"2002","unstructured":"Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse 3rd HC, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med. 2002;196:1415\u201325.","journal-title":"J Exp Med"},{"key":"785_CR29","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood-2007-07-100750","volume":"111","author":"P Tailor","year":"2008","unstructured":"Tailor P, Tamura T, Morse 3rd HC, Ozato K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood. 2008;111:1942\u20135.","journal-title":"Blood"},{"key":"785_CR30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4049\/jimmunol.170.3.1131","volume":"170","author":"H Tsujimura","year":"2003","unstructured":"Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein\/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol. 2003;170:1131\u20135.","journal-title":"J Immunol"},{"key":"785_CR31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1100066","volume":"365","author":"S Hambleton","year":"2011","unstructured":"Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365:127\u201338.","journal-title":"N Engl J Med"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0785-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:08:53Z","timestamp":1692036533000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/17\/1\/275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0785-0","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"article-number":"275"}}